Blasi, M., Kazdal, D., Thomas, M., Christopoulos, P., Kriegsmann, M., Brandt, R., . . . Kuon, J. (2021). Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer with Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case Report. Case Rep Oncol.
Citação norma ChicagoBlasi, Miriam, et al. "Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer With Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case Report." Case Rep Oncol 2021.
Citação norma MLABlasi, Miriam, et al. "Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer With Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case Report." Case Rep Oncol 2021.